Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cullinan Therapeutics, Inc.(CGEM) | 7,648,268 | 7,648,268 | 0 | $93.16M | $57.90M | 9.95% | -$35.26M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 0 | 100,415 | +100,415 | $0 | $33.26M | 5.72% | +$33.26M |
| Zai Lab LimitedADR(ZLAB) | 800,000 | 833,659 | +33,659 | $20.95M | $30.13M | 5.18% | +$9.18M |
| Edgewise Therapeutics, Inc.(EWTX) | 1,079,316 | 1,105,444 | +26,128 | $28.82M | $24.32M | 4.18% | -$4.50M |
| Lantheus Holdings, Inc.(LNTH) | 236,213 | 232,387 | -3,826 | $21.13M | $22.68M | 3.90% | +$1.55M |
| PTC Therapeutics, Inc.(PTCT) | 434,767 | 439,977 | +5,210 | $19.63M | $22.42M | 3.85% | +$2.80M |
| Natera, Inc.(NTRA) | 160,626 | 157,047 | -3,579 | $25.43M | $22.21M | 3.82% | -$3.22M |
| Trevi Therapeutics, Inc.(TRVI) | 3,094,896 | 3,428,366 | +333,470 | $12.75M | $21.56M | 3.71% | +$8.81M |
| Crinetics Pharmaceuticals Inc. | 617,035 | 631,964 | +14,929 | $31.55M | $21.20M | 3.64% | -$10.35M |
| Avidity Biosciences Inc | 702,981 | 714,224 | +11,243 | $20.44M | $21.08M | 3.62% | +$641.2K |
| Guardant Health, Inc.(GH) | 452,739 | 442,656 | -10,083 | $13.83M | $18.86M | 3.24% | +$5.03M |
| United Therapeutics Corporation(UTHR) | 23,000 | 58,907 | +35,907 | $8.12M | $18.16M | 3.12% | +$10.04M |
| ARS Pharmaceuticals, Inc.(SPRY) | 0 | 1,313,104 | +1,313,104 | $0 | $16.52M | 2.84% | +$16.52M |
| Compass Therapeutics, Inc.(CMPX) | 8,567,896 | 8,442,783 | -125,113 | $12.42M | $16.04M | 2.76% | +$3.62M |
| Janux Therapeutics, Inc.(JANX) | 230,000 | 567,193 | +337,193 | $12.31M | $15.31M | 2.63% | +$3.00M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 391,018 | 398,445 | +7,427 | $16.45M | $14.43M | 2.48% | -$2.02M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 315,230 | 316,049 | +819 | $17.07M | $12.35M | 2.12% | -$4.72M |
| Wave Life Sciences, Inc.(WVE) | 1,489,237 | 1,509,580 | +20,343 | $18.42M | $12.20M | 2.10% | -$6.22M |
| Revolution Medicines, Inc.(RVMD) | 313,817 | 317,083 | +3,266 | $13.73M | $11.21M | 1.93% | -$2.51M |
| Alkermes plc(ALKS) | 0 | 337,603 | +337,603 | $0 | $11.15M | 1.92% | +$11.15M |
| Olema Oncology, Inc.(OLMA) | 2,912,550 | 2,930,446 | +17,896 | $16.98M | $11.02M | 1.89% | -$5.96M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 1,020,559 | 1,618,265 | +597,706 | $12.83M | $10.79M | 1.86% | -$2.03M |
| iTeos Therapeutics, Inc. | 1,745,943 | 1,745,943 | 0 | $13.41M | $10.42M | 1.79% | -$2.99M |
| Cartesian Therapeutics, Inc.(RNAC) | 721,139 | 790,779 | +69,640 | $12.92M | $10.42M | 1.79% | -$2.49M |
| Twist Bioscience Corporation(TWST) | 267,497 | 261,215 | -6,282 | $12.43M | $10.26M | 1.76% | -$2.18M |
| Xenon Pharmaceuticals Inc.(XENE) | 197,212 | 303,398 | +106,186 | $7.73M | $10.18M | 1.75% | +$2.45M |
| Vera Therapeutics, Inc.CL A(VERA) | 257,788 | 415,719 | +157,931 | $10.90M | $9.99M | 1.72% | -$916.3K |
| Replimune Group, Inc.(REPL) | 950,000 | 987,036 | +37,036 | $11.50M | $9.62M | 1.65% | -$1.88M |
| Iovance Biotherapeutics, Inc.(IOVA) | 2,673,905 | 2,708,582 | +34,677 | $19.79M | $9.02M | 1.55% | -$10.77M |
| Context Therapeutics Inc.(CNTX) | 14,705,882 | 14,705,882 | 0 | $15.44M | $9.00M | 1.55% | -$6.44M |
| MBX Biosciences, Inc.(MBX) | 0 | 1,132,950 | +1,132,950 | $0 | $8.36M | 1.44% | +$8.36M |
| Nuvation Bio Inc.(NUVB) | 4,164,178 | 4,652,243 | +488,065 | $11.08M | $8.19M | 1.41% | -$2.89M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 1,399,514 | +1,399,514 | $0 | $7.81M | 1.34% | +$7.81M |
| IDEAYA Biosciences, Inc.(IDYA) | 414,035 | 430,161 | +16,126 | $10.64M | $7.05M | 1.21% | -$3.59M |
| Solid Biosciences Inc | 0 | 1,642,356 | +1,642,356 | $0 | $6.08M | 1.04% | +$6.08M |
| Relay Therapeutics, Inc.(RLAY) | 2,268,825 | 2,295,924 | +27,099 | $9.35M | $6.02M | 1.03% | -$3.33M |
| Stoke Therapeutics, Inc.(STOK) | 685,826 | 693,988 | +8,162 | $7.56M | $4.62M | 0.79% | -$2.95M |
| Veru Inc.(VERU) | 4,285,365 | 6,592,727 | +2,307,362 | $2.79M | $3.23M | 0.56% | +$443.5K |
| Werewolf Therapeutics, Inc.(HOWL) | 2,388,011 | 2,408,810 | +20,799 | $3.53M | $2.34M | 0.40% | -$1.19M |
| Design Therapeutics, Inc.(DSGN) | 559,547 | 562,943 | +3,396 | $3.45M | $2.17M | 0.37% | -$1.28M |
| Adaptimmune Therapeutics plcADR(ADAPY) | 5,095,912 | 4,894,344 | -201,568 | $2.75M | $964.2K | 0.17% | -$1.78M |
| Repare Therapeutics, Inc. | 1,231,154 | 819,924 | -411,230 | $1.61M | $808.4K | 0.14% | -$804.4K |
| ALX Oncology Holdings Inc.(ALXO) | 1,391,434 | 550,000 | -841,434 | $2.32M | $342.6K | 0.06% | -$1.98M |
| Akero Therapeutics Inc | 460,617 | 0 | -460,617 | $12.81M | $0 | — | -$12.81M |
| Aquestive Therapeutics Inc | 1,611,833 | 0 | -1,611,833 | $5.74M | $0 | — | -$5.74M |
| Arcturus Therapeutics Holdings Inc.(ARCT) | 459,943 | 0 | -459,943 | $7.81M | $0 | — | -$7.81M |
| Axsome Therapeutics, Inc.(AXSM) | 50,000 | 0 | -50,000 | $4.23M | $0 | — | -$4.23M |
| Disc Medicine, Inc.(IRON) | 346,401 | 0 | -346,401 | $21.96M | $0 | — | -$21.96M |
| Insmed Incorporated(INSM) | 389,611 | 0 | -389,611 | $26.90M | $0 | — | -$26.90M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 589,579 | 0 | -589,579 | $24.38M | $0 | — | -$24.38M |
| Scholar Rock Holding Corporation(SRRK) | 416,144 | 0 | -416,144 | $17.99M | $0 | — | -$17.99M |
| Sutro Biopharma, Inc.(STRO) | 2,160,062 | 0 | -2,160,062 | $3.97M | $0 | — | -$3.97M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 1,106,851 | 0 | -1,106,851 | $3.35M | $0 | — | -$3.35M |